# PTCy and ATG for MSD and MUD Transplants

> **NCT06299462** · PHASE1,PHASE2 · RECRUITING · sponsor: **Instituto Nacional de Cancer, Brazil** · enrollment: 50 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Hodgkin Lymphoma
- Non-hodgkin Lymphoma

## Interventions

- **DRUG:** ATG 5.0
- **DRUG:** Cyclophosphamide injection
- **DRUG:** ATG 4.0

## Key facts

- **NCT ID:** NCT06299462
- **Lead sponsor:** Instituto Nacional de Cancer, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-14
- **Primary completion:** 2031-06-01
- **Final completion:** 2031-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06299462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06299462, "PTCy and ATG for MSD and MUD Transplants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06299462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*